TELA Bio, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 78.47 M

TELA Bio, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 78.47 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -0.45% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • TELA Bio, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 78.82 M, a 28.41% change year over year.
  • TELA Bio, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 61.38 M, a 35.49% change year over year.
  • TELA Bio, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 45.30 M, a 35.14% change year over year.
  • TELA Bio, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 33.52 M, a 25.31% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue